The platform allows to connect specialized intelligent agents to the remote dialogue “patient-doctor”, which realize a certain set of functions relevant for this patient in automatic mode (but under the supervision of the attending physician).
For patients with hypertension, this platform can be used as a control of blood pressure and medication, as well as monitoring the effectiveness of the prescribed therapy;
for cancer patients – monitoring of their condition and well-being, with the aim of early detection of complications and side effects of treatment;
for pregnant women – control of blood pressure, weight and fetal movements, as well as reminders of the passage of necessary studies and visits to doctors and much more.
Also Medsenger.AI platform can be used by third-party developers to create special intelligent agents that solve specific medical problems, providing remote monitoring, control, counseling and patient management. Wherein, developers implement only an intelligent algorithm that solves a medical problem, and all communication, organizational and technical aspects of interaction with patients, doctors and medical organizations are provided by the Medsenger.AI platform.
The project was implemented with the support of a grant from the Fund for the Promotion of the Development of Small Forms of Enterprises in the Scientific and Technical Field (Innovation Promotion Fund), agreement No. 17ГС1НТИС5 / 43223 09/18/2018).
The platform received the Certificate on state registration of a computer program No. 2019619421 of July 17, 2019.
Information for developers of specialized intelligent agents is available here.